allowed to both dispense and prescribe medications. I examine this problem in the demand of the anti-diabetic drugs market … owned by government. Medical providers are less price-sensitive to generic drugs than the brand-name drugs. The demand of …

incorporate Ricardo's insight about demand-driven productivity in settings of variable scarce resources, and estimate the industry …'s responsiveness to changes in demand over this timeframe using therapeutic class-specific data. In contrast to many analyses, our … empirical estimates indicate that the industry has "met demand" with remarkable consistency since the late-1980s. The growth in …

, Switzerland introduced out-of-pocket price differentiation. As of July 1st 2011, substitutable pharmaceuticals with prices above a … from public sources and patient drug use data from two Swiss health insurers, we analyze the price and demand response of … from generic producers than from firms producing brand-name drugs. Regarding demand, we exploit a natural experiment in …

incorporate Ricardo's insight about demand-driven productivity in settings of variable scarce resources, and estimate the industry …'s responsiveness to changes in demand over this timeframe using therapeutic class-specific data. In contrast to many analyses, our … empirical estimates indicate that the industry has “met demand” with remarkable consistency since the late-1980s. The growth in …